AAAAAA
Results:
1-8
|
Results: 8
Authors:
CRONIN CC
JACKSON LM
FEIGHERY C
SHANAHAN F
ABUZAKOUK M
RYDER DQ
WHELTON M
CALLAGHAN N
Citation: Cc. Cronin et al., CELIAC-DISEASE AND EPILEPSY, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(4), 1998, pp. 303-308
Authors:
CHADWICK D
BEGHI E
CALLAGHAN N
DEBITTENCOURT P
DULAC O
GRAM L
JOHNSON AL
MATTSON R
PISANI F
PORTER RJ
RICHENS A
SCHMIDT D
VANDONSELAAR CA
Citation: D. Chadwick et al., CONSIDERATIONS ON DESIGNING CLINICAL-TRIALS TO EVALUATE THE PLACE OF NEW ANTIEPILEPTIC DRUGS IN THE TREATMENT OF NEWLY-DIAGNOSED AND CHRONIC-PATIENTS WITH EPILEPSY, Epilepsia, 39(7), 1998, pp. 799-803
Authors:
JACKSON LM
CRONIN CC
SHANAHAN F
RYDER DQ
CALLAGHAN N
FEIGHERY C
Citation: Lm. Jackson et al., CELIAC-DISEASE AND EPILEPSY, Gastroenterology, 112(4), 1997, pp. 372-372
Authors:
WEBB S
FLANAGAN N
CALLAGHAN N
HUTCHINSON M
Citation: S. Webb et al., A FAMILY WITH HEREDITARY SPASTIC PARAPARESIS AND EPILEPSY, Epilepsia, 38(4), 1997, pp. 495-499
Authors:
CRONIN CC
CALLAGHAN N
KEARNEY PJ
MURNAGHAN DJ
SHANAHAN F
Citation: Cc. Cronin et al., ADDISON-DISEASE IN PATIENTS TREATED WITH GLUCOCORTICOID THERAPY, Archives of internal medicine, 157(4), 1997, pp. 456-458
Authors:
HENRY M
MURPHY K
CALLAGHAN N
MITCHELL TH
Citation: M. Henry et al., DIABETIC NEUROPATHY AND DOPAMINE-BETA-HYDROXYLASE, Journal of drug development and clinical practice, 8(1), 1996, pp. 47-48
Authors:
CALLAGHAN N
Citation: N. Callaghan, MEDICAL OPTIONS IN THE TREATMENT OF GENERALIZED SEIZURES IN ADULTS, Irish medical journal, 88(6), 1995, pp. 193
Authors:
CALLAGHAN N
MAJEED T
OCONNELL A
OLIVEIRA DBG
Citation: N. Callaghan et al., A COMPARATIVE-STUDY OF SERUM-F-PROTEIN AND OTHER LIVER-FUNCTION TESTSAS AN INDEX OF HEPATOCELLULAR DAMAGE IN EPILEPTIC PATIENTS, Acta neurologica Scandinavica, 89(4), 1994, pp. 237-241
Risultati:
1-8
|